GR3031710T3 - Oxazolidinone derivatives, their preparation and therapeutical use - Google Patents

Oxazolidinone derivatives, their preparation and therapeutical use

Info

Publication number
GR3031710T3
GR3031710T3 GR990402802T GR990402802T GR3031710T3 GR 3031710 T3 GR3031710 T3 GR 3031710T3 GR 990402802 T GR990402802 T GR 990402802T GR 990402802 T GR990402802 T GR 990402802T GR 3031710 T3 GR3031710 T3 GR 3031710T3
Authority
GR
Greece
Prior art keywords
preparation
oxazolidinone derivatives
therapeutical use
therapeutical
oxazolidinone
Prior art date
Application number
GR990402802T
Other languages
English (en)
Inventor
Samir Jegham
Frederic Puech
Philippe Burnier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3031710(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr
Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of GR3031710T3 publication Critical patent/GR3031710T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR990402802T 1995-06-02 1999-11-03 Oxazolidinone derivatives, their preparation and therapeutical use GR3031710T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9506563A FR2734820B1 (fr) 1995-06-02 1995-06-02 Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506564A FR2734821B1 (fr) 1995-06-02 1995-06-02 Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/000792 WO1996038444A1 (fr) 1995-06-02 1996-05-28 Derives d'oxazolidinone, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
GR3031710T3 true GR3031710T3 (en) 2000-02-29

Family

ID=26232004

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402802T GR3031710T3 (en) 1995-06-02 1999-11-03 Oxazolidinone derivatives, their preparation and therapeutical use

Country Status (27)

Country Link
US (1) US5843975A (el)
EP (1) EP0835254B1 (el)
JP (1) JP3856829B2 (el)
KR (1) KR100457502B1 (el)
CN (1) CN1075072C (el)
AR (1) AR006301A1 (el)
AT (1) ATE184005T1 (el)
AU (1) AU699367B2 (el)
BR (1) BR9608896A (el)
CA (1) CA2223011C (el)
CO (1) CO4700462A1 (el)
CZ (1) CZ378497A3 (el)
DE (1) DE69604071T2 (el)
DK (1) DK0835254T3 (el)
ES (1) ES2138346T3 (el)
GR (1) GR3031710T3 (el)
HK (1) HK1014938A1 (el)
HU (1) HU224879B1 (el)
MX (1) MX9709410A (el)
NO (1) NO309091B1 (el)
NZ (1) NZ310487A (el)
PL (1) PL183919B1 (el)
RU (1) RU2164226C2 (el)
SK (1) SK281934B6 (el)
TW (1) TW360654B (el)
WO (1) WO1996038444A1 (el)
ZA (1) ZA964563B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
HUP0401858A3 (en) * 2001-01-31 2009-06-29 Lundbeck & Co As H Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
IL160744A0 (en) * 2001-09-26 2004-08-31 Pharmacia Italia Spa Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
EP2032565A2 (en) * 2006-02-01 2009-03-11 Pfizer Products Inc. Benzisoxazole oxazolidinones as antibacterial agents
EP2141154A4 (en) * 2007-03-30 2011-06-01 Inst Med Molecular Design Inc OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11-HYDROXYSTEOID DEHYDROGENASE TYPE I
EP2123159A1 (de) * 2008-05-21 2009-11-25 Bayer CropScience AG (1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
JP2013514385A (ja) * 2009-12-18 2013-04-25 ヤンセン ファーマシューティカ エヌ．ベー． エストロゲン関連受容体αモジュレーターとしての置換アミノチアゾロンインダゾール
RU2012139459A (ru) * 2010-02-17 2014-03-27 Янссен Фармацевтика Нв Аминотиазолоны для использования в качестве модуляторов родственных эстрогену рецепторов альфа
WO2016097355A1 (en) * 2014-12-19 2016-06-23 Ge Healthcare Limited Labelled oxazolidinone derivatives
DE102015012050A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) * 2016-09-05 2017-12-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ) Иммунодепрессант

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
AU1209092A (en) * 1991-02-20 1992-09-15 Yusaku Koda Articulator

Also Published As

Publication number Publication date
PL183919B1 (pl) 2002-08-30
SK281934B6 (sk) 2001-09-11
TW360654B (en) 1999-06-11
ZA964563B (en) 1996-12-12
JPH11507330A (ja) 1999-06-29
ATE184005T1 (de) 1999-09-15
RU2164226C2 (ru) 2001-03-20
HUP9901349A2 (hu) 1999-08-30
CN1075072C (zh) 2001-11-21
NO309091B1 (no) 2000-12-11
CA2223011A1 (en) 1996-12-05
EP0835254B1 (fr) 1999-09-01
HUP9901349A3 (en) 2000-02-28
WO1996038444A1 (fr) 1996-12-05
JP3856829B2 (ja) 2006-12-13
PL323673A1 (en) 1998-04-14
KR19990022187A (ko) 1999-03-25
CA2223011C (en) 2007-01-09
ES2138346T3 (es) 2000-01-01
SK161497A3 (en) 1998-05-06
US5843975A (en) 1998-12-01
CO4700462A1 (es) 1998-12-29
DE69604071T2 (de) 2000-04-06
BR9608896A (pt) 1999-06-29
HK1014938A1 (en) 1999-10-08
DK0835254T3 (da) 2000-03-27
DE69604071D1 (de) 1999-10-07
EP0835254A1 (fr) 1998-04-15
MX9709410A (es) 1998-07-31
CZ378497A3 (cs) 1998-04-15
NO975530L (no) 1998-02-02
HU224879B1 (en) 2006-03-28
AU6128896A (en) 1996-12-18
KR100457502B1 (ko) 2005-09-05
NZ310487A (en) 1999-05-28
AU699367B2 (en) 1998-12-03
AR006301A1 (es) 1999-08-25
NO975530D0 (no) 1997-12-01
CN1191534A (zh) 1998-08-26

Similar Documents

Publication Publication Date Title
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
HUP9801817A3 (en) Dolastatin derivatives, their preparation and use
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
AU7095296A (en) Phosphorylamides, their preparation and use
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
GR3031710T3 (en) Oxazolidinone derivatives, their preparation and therapeutical use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU7135996A (en) Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof
HUP9900064A3 (en) Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
HK1016166A1 (en) 5-naphthalen-1-yl-1, 3-dioxane derivatives, preparation and therapeutical use thereof
IL122686A0 (en) Benzylhydroxylamines their preparation and use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
HRP960400B1 (en) New carbonic acid derivatives, their preparation and their use
AU6298196A (en) Tetrahydro-betacarboline derivatives and their preparation and use
AU6934396A (en) 1-phenyl-3-4-{benzylpiperidinyl-1}-propanol-1 derivatives, preparation thereof and therapeutical application thereof
ZA963999B (en) 3,4-Disubstituted-phenylsulphonamides and their therapeutic use